Schering Rebetol Costs $1,650 Per Month, 3% Less Than Combo Rebetron
Executive Summary
Schering-Plough's Rebetol is 97% of the cost for its hepatitis C combination product Rebetron that includes Rebetol and Intron-A.
You may also be interested in...
Ribavirin ANDAs Await ICN Petition; FDA Generic Rule Takes Effect
The delay in approval for generic versions of Schering-Plough's Rebetol (ribavirin) illustrates one limitation of FDA's revised Waxman/Hatch regulations
Ribavirin ANDAs Await ICN Petition; FDA Generic Rule Takes Effect
The delay in approval for generic versions of Schering-Plough's Rebetol (ribavirin) illustrates one limitation of FDA's revised Waxman/Hatch regulations
PEG-Intron Access Program Requires ID Number, Designed To Ensure Supply
Schering-Plough is implementing a prescription tracking program for PEG-Intron to ensure that existing patients will have adequate supply of peginterferon alfa-2b